1. Home
  2. GDYN vs TECX Comparison

GDYN vs TECX Comparison

Compare GDYN & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grid Dynamics Holdings Inc.

GDYN

Grid Dynamics Holdings Inc.

SELL

Current Price

$7.67

Market Cap

653.5M

Sector

Technology

ML Signal

SELL

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$20.96

Market Cap

618.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDYN
TECX
Founded
2006
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
653.5M
618.9M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
GDYN
TECX
Price
$7.67
$20.96
Analyst Decision
Buy
Strong Buy
Analyst Count
6
10
Target Price
$9.40
★ $71.00
AVG Volume (30 Days)
★ 755.3K
232.9K
Earning Date
10-29-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 120.00
40.70
EPS
★ 0.02
N/A
Revenue
★ $111,283,000.00
N/A
Revenue This Year
$6.37
N/A
Revenue Next Year
$8.70
N/A
P/E Ratio
$389.00
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.11
$15.60
52 Week High
$10.21
$39.53

Technical Indicators

Market Signals
Indicator
GDYN
TECX
Relative Strength Index (RSI) 46.40 27.01
Support Level $7.56 $20.52
Resistance Level $8.22 $30.80
Average True Range (ATR) 0.27 1.23
MACD -0.03 0.07
Stochastic Oscillator 16.93 12.66

Price Performance

Historical Comparison
GDYN
TECX

About GDYN Grid Dynamics Holdings Inc.

Grid Dynamics Holdings Inc is a provider of technology consulting, platform and product engineering, and advanced analytics services. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: